Belvedere Trading
ELV icon

Belvedere Trading’s Elevance Health ELV Stock Holding History

Belvedere Trading’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6,080
Closed -$764K – 120
2014
Q4 		$764K Buy
+6,080
New +$751K 0.01% 150

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Belvedere Trading's ELV Position: Q1 2015 in Review

Belvedere Trading sold out of Elevance Health (ELV) in Q1 2015, closing a stake of 6,080 shares — an estimated $764K sold.

Belvedere Trading first reported a position in ELV in Q4 2014 and held it in 1 quarter. The position peaked at $764K in Q4 2014. 752 funds tracked by Wall St. Rank hold ELV as of Q1 2015.

  • Belvedere Trading reported no remaining Elevance Health position as of Q1 2015 after selling out during the quarter.
  • Belvedere Trading sold 6,080 Elevance Health shares in Q1 2015, an estimated $764K.
  • Belvedere Trading first reported a position in Elevance Health in Q4 2014 and held it in 1 quarter.
  • Belvedere Trading's Elevance Health position peaked at $764K in Q4 2014.
  • 752 funds tracked by Wall St. Rank held Elevance Health as of Q1 2015.

Based on Belvedere Trading's 13F filing for Q1 2015, filed 14 May 2015.